Learn
Looking for more information?
Contact our responsive and friendly client services team any time.
Current price
$0.039
▾0.00 (0.00%)
Last trade: 21/12, 4:11PM
Market cap
$5.67m
Trading Suspended
Talk to Genetic Technologies Limited directly.
Sign up to their Investor Hub for direct access to the Genetic Technologies Limited team, ask them questions, and see personal updates.
Investor Presentations
Principal Activity
Genetic Technologies Limited (GTG) is a molecular diagnostics company that offers predictive testing and assessment tools to help physicians proactively manage women's health. The Company's lead product is BREVAGenplus.
Address
60-66 Hanover St, Fitzroy VIC 3065, Australia
Website
News
Announcements
Filter
| Announcement | T+2 Movement | Date |
|---|---|---|
Market Data
Day
3m
1yr
5yr
Current price
$0.039
Open price
-
Day low-high
-
Price change
Percent change
Previous close
-
Volume
-
Turnover
-
Bid price
-
Ask price
-
Market cap
-
Shares outstanding
-
Year high
-
Year low
-
Year low-high
-
Earnings per share
-
Price/earnings ratio
-
Dividend yield
-
Dividend per share
-
Franking
-
Investor Presentations
News
Sector Peers
| Company | Market Cap | ||
|---|---|---|---|
Copyright © 2024 Fresh Equities. All rights reserved. ACN 619 657 028. CAR: 001267539 of AFSL: 471379.
Support
Live Chat
Markets
Copyright © 2024 Fresh Equities. All rights reserved. ACN 619 657 028. CAR: 001267539 of AFSL: 471379.